Healthy Volunteers Therapeutic Indication Not Studied clinical trials

Explore recruiting healthy volunteers therapeutic indication not studied clinical trials.

Also recruiting in Europe

Healthy Volunteers Therapeutic Indication Not Studied trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to assess Bioequivalence with Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Characterisation of availability in the body of the active substance(s) of the newly developed patch Esflurbiprofen Topical System (EFTS) in comparison with a marketed oral flurbiprofen-containing tablet formulation after multiple dose administration including adhesion assessment of the patch - a phase I, open-label, randomised, 2-period, cross-over study in healthy subjects

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A randomized, two-way, crossover, two parallel groups study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride tablets (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® tablets (Angelini Pharma S.p.A.) at steady-state

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Healthy Volunteers Therapeutic Indication Not Studied trials by city

Healthy Volunteers Therapeutic Indication Not Studied in Toronto Healthy Volunteers Therapeutic Indication Not Studied in Vancouver Healthy Volunteers Therapeutic Indication Not Studied in Montreal Healthy Volunteers Therapeutic Indication Not Studied in Calgary Healthy Volunteers Therapeutic Indication Not Studied in Edmonton Healthy Volunteers Therapeutic Indication Not Studied in Ottawa Healthy Volunteers Therapeutic Indication Not Studied in Winnipeg Healthy Volunteers Therapeutic Indication Not Studied in Quebec City Healthy Volunteers Therapeutic Indication Not Studied in Hamilton Healthy Volunteers Therapeutic Indication Not Studied in Kitchener Healthy Volunteers Therapeutic Indication Not Studied in London Healthy Volunteers Therapeutic Indication Not Studied in Halifax Healthy Volunteers Therapeutic Indication Not Studied in New York Healthy Volunteers Therapeutic Indication Not Studied in Los Angeles Healthy Volunteers Therapeutic Indication Not Studied in Chicago Healthy Volunteers Therapeutic Indication Not Studied in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease